Skip to main content
. Author manuscript; available in PMC: 2015 Dec 1.
Published in final edited form as: Clin Sci (Lond). 2014 Dec;127(11):645–654. doi: 10.1042/CS20140030

Table 3.

Brachial artery parameters during placebo and salsalate

Variable Young Non-exercising
Older Non-exercising
Older Exercise-Trained
Placebo Salsalate Placebo Salsalate Placebo Salsalate
Brachial artery diameter (mm) 4.0 ± 0.1 4.1 ± 0.1 3.9 ± 0.1 3.8 ± 0.2 3.7 ± 0.2 3.7 ± 0.2
FMD (mm change) 0.30 ± 0.03 0.33 ± 0.03 0.15 ± 0.02 * 0.25 ± 0.02 0.26 ± 0.02 0.27 ± 0.01
Peak shear rate (1/s) 808 ± 67 855 ± 70 840 ± 65 890 ± 68 941 ± 68 906 ± 53
GTN dilation (% change) 25 ± 1 24 ± 1 21 ± 2 22 ± 2 26 ± 2 24 ± 1
GTN dilation (mm change) 1.0 ± 0.1 1.0 ± 0.1 0.8 ± 0.1 0.9 ± 0.1 1.0 ± 0.1 1.0 ± 0.0

Data are mean ± SE. FMD, flow-mediated dilation; GTN, glyceryl trinitrate.

*

P<0.05 vs. young non-exercising placebo,

P<0.05 vs. older non-exercising placebo